BANF1 and idiopathic pulmonary fibrosis: Treatment of IPF fibroblasts with Aza, Ctd or Pirf resulted in a basal increase in the autophagy marker LC3BII as compared to vehicle‐treated cells and a further significant increase of LC3BII in the presence of Baf (Figure 3A).